Fate Therapeutics Inc.
Transforming the lives of patients with autoimmune diseases and cancer.
227 employees · est. 2007 · San Diego, United States
REPROCELL is the older company (2007 vs 2003); Fate Therapeutics Inc. is the larger of the two.
Side-by-Side Comparison
| Metric | Fate Therapeutics Inc. | REPROCELL |
|---|---|---|
| Founded | ||
| Founded | 2007 | 2003 older |
| Headquarters | ||
| Headquarters | San Diego, United States | Yokohama, Japan |
| Employees | ||
| Employees | 227 larger | 58 |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Biotechnology |
| Funding Stage | ||
| Funding Stage | Unknown | Unknown |
| Total Funding | ||
| Total Funding | $1.24B | $1.99M |
| Funding Rounds | ||
| Funding Rounds | 16 | 6 |
| Services | ||
| Services | Research and Development, Cell Therapy Development, Clinical Trials Management, Biopharmaceutical Manufacturing | End-to-End Solutions for Cell Therapy, Stem Cell and Gene Editing Services, Diagnostic Development Support, Preclinical and Clinical Drug Development Support, Biospecimen and Molecular Services |
| Target Customers | ||
| Target Customers | Patients with Autoimmune Diseases, Cancer Patients, Healthcare Providers, Biomedical Researchers | Cell Therapy Developers, Stem Cell Researchers, Diagnostic Developers, Preclinical Drug Developers, Clinical Drug Developers |
| Taxonomy | ||
| Taxonomy | IPSC-derived Cellular Immunotherapies, Stem Cell Therapeutics, Immuno-oncology, Autoimmune Diseases, Master IPSC Lines, Off-the-shelf Cell Products, NK Cell Product Candidates, T-cell Product Candidates, Synthetic Controls Of Cell Function, Multiplexed-engineered, Clinical-stage Biopharmaceutical, Cellular Immunotherapies, Regenerative Therapies, Stem Cell Modulators, Hematopoietic Progenitor Cells | Stem Cell Research, Pre-Clinical Drug Development, Human Tissue Access, Human Tissue Testing, Stem Cell Culture Media, IPSC Reprogramming Technologies, IPSC-Derived Cell Types, Bioengineered Tissue Models, Regenerative Medicine, GMP IPSC Master Cell Bank Manufacturing, Clinical-Grade Reagents And Services, Tissue Compatibility Diagnostics, Biomarker Testing, Pharmacology, 3D Tissue Models |
| Website | ||
| Website | fatetherapeutics.com | reprocell.com |
About Fate Therapeutics Inc.
Fate Therapeutics Inc., founded in 2007 and headquartered in the United States, is a clinical-stage biopharmaceutical leader with a compelling mission of "Transforming the lives of patients with autoimmune diseases and cancer." The company excels in the Biotechnology sector, offering innovative ind...
About REPROCELL
REPROCELL, founded in 2003, operates at the forefront of the Biotechnology industry with a mission encapsulated by its slogan, "Better Translating Discoveries into Therapies." The company specializes in comprehensive support for stem cell research and pre-clinical drug development. Its unique offer...
We will tell you when either one moves
BounceWatch watches Fate Therapeutics Inc. and REPROCELL for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Fate Therapeutics Inc. and REPROCELL — by email.
Frequently Asked Questions
Compare Fate Therapeutics Inc. with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Fate Therapeutics Inc. on 3 Jul 2026, and REPROCELL on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.